51 related articles for article (PubMed ID: 20631077)
1. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.
Okazaki F; Matsunaga N; Okazaki H; Utoguchi N; Suzuki R; Maruyama K; Koyanagi S; Ohdo S
Cancer Res; 2010 Aug; 70(15):6238-46. PubMed ID: 20631077
[TBL] [Abstract][Full Text] [Related]
2. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.
Candelaria PV; Leoh LS; Penichet ML; Daniels-Wells TR
Front Immunol; 2021; 12():607692. PubMed ID: 33815364
[TBL] [Abstract][Full Text] [Related]
3. MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis.
Cazarin J; DeRollo RE; Shahidan SNABA; Burchett JB; Mwangi D; Krishnaiah S; Hsieh AL; Walton ZE; Brooks R; Mello SS; Weljie AM; Dang CV; Altman BJ
PLoS Genet; 2023 Aug; 19(8):e1010904. PubMed ID: 37639465
[TBL] [Abstract][Full Text] [Related]
4. Structure prediction of transferrin receptor protein 1 (TfR1) by homology modelling, docking, and molecular dynamics simulation studies.
Al-Refaei MA; Makki RM; Ali HM
Heliyon; 2020 Jan; 6(1):e03221. PubMed ID: 32021925
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Resistance to Ionizing Radiation Exposure Is Accompanied by Decreased Cathepsin D and Increased Transferrin Receptor 1 Expression.
Pinto AT; Machado AB; Osório H; Pinto ML; Vitorino R; Justino G; Santa C; Castro F; Cruz T; Rodrigues C; Lima J; Sousa JLR; Cardoso AP; Figueira R; Monteiro A; Marques M; Manadas B; Pauwels J; Gevaert K; Mareel M; Rocha S; Duarte T; Oliveira MJ
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612268
[TBL] [Abstract][Full Text] [Related]
6. Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells.
Horiguchi M; Koyanagi S; Hamdan AM; Kakimoto K; Matsunaga N; Yamashita C; Ohdo S
Cancer Res; 2013 Apr; 73(8):2639-49. PubMed ID: 23580573
[TBL] [Abstract][Full Text] [Related]
7. Circadian molecular clocks and cancer.
Kelleher FC; Rao A; Maguire A
Cancer Lett; 2014 Jan; 342(1):9-18. PubMed ID: 24099911
[TBL] [Abstract][Full Text] [Related]
8. Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression.
Okazaki F; Matsunaga N; Okazaki H; Azuma H; Hamamura K; Tsuruta A; Tsurudome Y; Ogino T; Hara Y; Suzuki T; Hyodo K; Ishihara H; Kikuchi H; To H; Aramaki H; Koyanagi S; Ohdo S
J Biol Chem; 2016 Mar; 291(13):7017-28. PubMed ID: 26797126
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity.
Song J; Liu T; Yin Y; Zhao W; Lin Z; Yin Y; Lu D; You F
EMBO Rep; 2021 Feb; 22(2):e51162. PubMed ID: 33393230
[TBL] [Abstract][Full Text] [Related]
10. Iron metabolism in colorectal cancer.
Huang L; Li W; Lu Y; Ju Q; Ouyang M
Front Oncol; 2023; 13():1098501. PubMed ID: 36910614
[TBL] [Abstract][Full Text] [Related]
11. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis indicates the prognostic value of circadian rhythm disruption in liver cancer: Potential for therapeutic targeting.
Wang RQ; Cui W; Cai J; Sun Y
Front Immunol; 2022; 13():1011264. PubMed ID: 36569894
[TBL] [Abstract][Full Text] [Related]
13. Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns.
Qu L; He X; Tang Q; Fan X; Liu J; Lin A
J Zhejiang Univ Sci B; 2022 Oct; 23(10):844-862. PubMed ID: 36226538
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
15. The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS-CoV-2 and Its Potential Cell Surface Receptors.
Dai J; Teng X; Jin S; Wu Y
Oxid Med Cell Longev; 2021; 2021():7866992. PubMed ID: 34497683
[TBL] [Abstract][Full Text] [Related]
16. Targeting iron metabolism in cancer therapy.
Morales M; Xue X
Theranostics; 2021; 11(17):8412-8429. PubMed ID: 34373750
[TBL] [Abstract][Full Text] [Related]
17. Exploring the link between chronobiology and drug delivery: effects on cancer therapy.
Albuquerque T; Neves AR; Quintela T; Costa D
J Mol Med (Berl); 2021 Oct; 99(10):1349-1371. PubMed ID: 34213595
[TBL] [Abstract][Full Text] [Related]
18. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients.
Ginghină O; Hudiță A; Zaharia C; Tsatsakis A; Mezhuev Y; Costache M; Gălățeanu B
Materials (Basel); 2021 May; 14(9):. PubMed ID: 34066710
[TBL] [Abstract][Full Text] [Related]
19. Transferrin receptor 1 in cancer: a new sight for cancer therapy.
Shen Y; Li X; Dong D; Zhang B; Xue Y; Shang P
Am J Cancer Res; 2018; 8(6):916-931. PubMed ID: 30034931
[TBL] [Abstract][Full Text] [Related]
20. Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in Cancer.
Altman BJ
Front Cell Dev Biol; 2016; 4():62. PubMed ID: 27500134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
